Correlation Between Citigroup and Arcturus Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Arcturus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Arcturus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Arcturus Therapeutics Holdings, you can compare the effects of market volatilities on Citigroup and Arcturus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Arcturus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Arcturus Therapeutics.

Diversification Opportunities for Citigroup and Arcturus Therapeutics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Citigroup and Arcturus is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Arcturus Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcturus Therapeutics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Arcturus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcturus Therapeutics has no effect on the direction of Citigroup i.e., Citigroup and Arcturus Therapeutics go up and down completely randomly.

Pair Corralation between Citigroup and Arcturus Therapeutics

Taking into account the 90-day investment horizon Citigroup is expected to generate 0.35 times more return on investment than Arcturus Therapeutics. However, Citigroup is 2.86 times less risky than Arcturus Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Arcturus Therapeutics Holdings is currently generating about 0.03 per unit of risk. If you would invest  4,492  in Citigroup on November 28, 2024 and sell it today you would earn a total of  3,322  from holding Citigroup or generate 73.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Citigroup  vs.  Arcturus Therapeutics Holdings

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Arcturus Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Arcturus Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Citigroup and Arcturus Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Arcturus Therapeutics

The main advantage of trading using opposite Citigroup and Arcturus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Arcturus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcturus Therapeutics will offset losses from the drop in Arcturus Therapeutics' long position.
The idea behind Citigroup and Arcturus Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges